CXCL12 and chronic myelogenous leukemia, BCR-ABL1 positive: Perturbation of the CXCR4/CXCL12 interaction with AMD3100 promotes egress of CML LSCs and progenitor cells from the bone marrow niche, potentially increasing their susceptibility to targeted strategies currently being evaluated in clinical trials.